Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

348255

registered interest
date	03/06/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Mental Health Services: West Midlands
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what plans his Department has to review mental health provision in the West Midlands; and if he will make a statement.
tabling member constituency	Coventry South
tabling member printed	Mr Jim Cunningham
uin	1026
answer	answer is ministerial correction date of answer 08/06/2015 answer text <p>This is a matter for the National Health Service locally. NHS England advises that Coventry and Rugby Clinical Commissioning Group (CCG), is working along with South Warwickshire CCG, Warwickshire North CCG, Coventry City Council and Warwickshire County Council, on a joint review of the specifications for children and adolescent mental health services.</p><p> </p><p> </p><p> </p><p>In the current financial year Coventry and Rugby CCG will put an additional £1.2 million towards the mental health services it commissions.</p><p> </p> answering member constituency North East Bedfordshire answering member printed Alistair Burt grouped question UIN 1027 question first answered 08/06/2015 14:24:51 answering member 1201 label Biography information for Alistair Burt
tabling member	308 label Biography information for Mr Jim Cunningham

348256

registered interest
date	03/06/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Mental Health Services: West Midlands
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what plans his Department has to make additional resources available for mental health services in the West Midlands over the next five years; and if he will make a statement.
tabling member constituency	Coventry South
tabling member printed	Mr Jim Cunningham
uin	1027
answer	answer is ministerial correction date of answer 08/06/2015 answer text <p>This is a matter for the National Health Service locally. NHS England advises that Coventry and Rugby Clinical Commissioning Group (CCG), is working along with South Warwickshire CCG, Warwickshire North CCG, Coventry City Council and Warwickshire County Council, on a joint review of the specifications for children and adolescent mental health services.</p><p> </p><p> </p><p> </p><p>In the current financial year Coventry and Rugby CCG will put an additional £1.2 million towards the mental health services it commissions.</p><p> </p> answering member constituency North East Bedfordshire answering member printed Alistair Burt grouped question UIN 1026 question first answered 08/06/2015 14:24:51 answering member 1201 label Biography information for Alistair Burt
tabling member	308 label Biography information for Mr Jim Cunningham

348257

registered interest
date	03/06/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Antimicrobials: Drug Resistance
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what plans his Department has to make additional funding available to tackle drug-resistant infections over the next five years.
tabling member constituency	Coventry South
tabling member printed	Mr Jim Cunningham
uin	1028
answer	answer is ministerial correction date of answer 08/06/2015 answer text <p>The health and care system across the United Kingdom is taking action against the growing threat of infections that are resistant to the antimicrobial drugs used to treat them.</p><p> </p><p> </p><p> </p><p>In December 2014, we published the UK Five Year AMR Strategy detailed implementation plan. The plan set out those activities that needed to be undertaken to deliver the strategy in each of seven key areas for action. Activity in the plan is led by the Department of Health, Public Health England, Department for Environment, Food and Rural Affairs and NHS England and is incorporated within existing business plans for those organisations.</p><p> </p><p> </p><p> </p><p>The Government has no current plans to make additional funding available to tackle drug-resistant infections. Any proposals for funding would be subject to the outcome of the Spending Review later this year.</p><p> </p><p> </p><p> </p> answering member constituency Battersea answering member printed Jane Ellison question first answered 08/06/2015 10:54:59 answering member 3918 label Biography information for Jane Ellison
tabling member	308 label Biography information for Mr Jim Cunningham

348258

registered interest
date	03/06/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Infectious Diseases
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what estimate he has made of the number of drug-resistant infections (a) in the West Midlands and (b) nationally in the next five years.
tabling member constituency	Coventry South
tabling member printed	Mr Jim Cunningham
uin	1029
answer	answer is ministerial correction date of answer 08/06/2015 answer text <p>Public Health England (PHE) has published no estimates for the number of drug-resistant infections in the West Midlands or nationally over the next five years. The science of drug resistant infections is incompletely understood and is rapidly changing and evolving. Multi-drug resistant infections are unpredictable in their occurrence and can rapidly change. For these reasons producing estimates of the likely burden in future years is unlikely to be meaningful or robust.</p><p> </p><p> </p><p> </p><p>Antimicrobial resistance is a priority for PHE who are working to improve surveillance and knowledge in this area. Specific antimicrobial resistant infections have been measured by PHE and openly published in weekly Health Protection Reports.</p><p> </p> answering member constituency Battersea answering member printed Jane Ellison question first answered 08/06/2015 10:58:32 answering member 3918 label Biography information for Jane Ellison
tabling member	308 label Biography information for Mr Jim Cunningham

348259

registered interest
date	03/06/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Batten Disease: Health Services
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what assessment he has made of the adequacy of provisions to treat people who have Batten Disease.
tabling member constituency	Leeds North West
tabling member printed	Greg Mulholland
uin	994
answer	answer is ministerial correction date of answer 12/06/2015 answer text <p>The neuronal ceriod lipofuscinoses (Batten disease) are a set of severely disabling degenerative diseases. Care is given in regional paediatric neuroscience centres and by local teams. We are advised by NHS England that it is at an early stage of discussion about the possibility of establishing expert centres for Batten disease. This disease does not feature in the highly specialised work programme for 2015/16 but NHS England will be considering it for inclusion in the 2016/17 work programme.</p><p> </p> answering member constituency Battersea answering member printed Jane Ellison question first answered 12/06/2015 10:58:52 answering member 3918 label Biography information for Jane Ellison
tabling member	1540 label Biography information for Greg Mulholland

348260

registered interest
date	03/06/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Batten Disease: Health Services
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what steps he is taking to support research into the treatment of Batten Disease.
tabling member constituency	Leeds North West
tabling member printed	Greg Mulholland
uin	995
answer	answer is ministerial correction date of answer 12/06/2015 answer text <p>The National Institute for Health Research (NIHR) Clinical Research Network is hosting a commercial study to evaluate the safety and effectiveness of cerliponase alfa in patients with late-infantile neuronal ceroid lipofuscinosis type 2, a form of Batten disease. The NIHR also welcomes funding applications for research into any aspect of human health, including treatment of Batten disease. These applications are subject to peer review and judged in open competition, with awards being made on the basis of the importance of the topic to patients and health and care services, value for money and scientific quality.</p><p> </p> answering member constituency Mid Norfolk answering member printed George Freeman question first answered 12/06/2015 10:53:53 answering member 4020 label Biography information for George Freeman
tabling member	1540 label Biography information for Greg Mulholland

348267

registered interest
date	03/06/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Abortion: Costs
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what recent estimate he has made of the cost to the public purse of NHS abortion services from May 2010 to April 2015.
tabling member constituency	North Antrim
tabling member printed	Ian Paisley
uin	1015
answer	answer is ministerial correction date of answer 09/06/2015 answer text <p>Information about expenditure on termination of pregnancy services is not collected centrally.</p><p> </p> answering member constituency Battersea answering member printed Jane Ellison question first answered 09/06/2015 11:56:55 answering member 3918 label Biography information for Jane Ellison
tabling member	4129 label Biography information for Ian Paisley

348268

registered interest
date	03/06/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	IVF: Licensing
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what estimate he has made of the number of licences the Human Fertilisation and Embryology Authority will grant under the Human Fertilisation and Embryology (Mitochondrial Donation) Regulations 2015 over the next three years.
tabling member constituency	North Antrim
tabling member printed	Ian Paisley
uin	1046
answer	answer is ministerial correction date of answer 12/06/2015 answer text <p>The Department has made no estimate of the number of licences that the Human Fertilisation and Embryology Authorisation (HFEA) might grant over the next three years.</p><p> </p><p> </p><p> </p><p>The HFEA will make an assessment of applications as set out in the Human Fertilisation and Embryology (Mitochondrial Donation) Regulations 2015.</p><p> </p> answering member constituency Battersea answering member printed Jane Ellison question first answered 12/06/2015 10:55:23 answering member 3918 label Biography information for Jane Ellison
tabling member	4129 label Biography information for Ian Paisley

348269

registered interest
date	03/06/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Gene Therapies
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, whether it is his policy to permit Clustered Regularly Interspaced Short Palindromic Repeats techniques in the UK.
tabling member constituency	North Antrim
tabling member printed	Ian Paisley
uin	1099
answer	answer is ministerial correction date of answer 12/06/2015 answer text <p>The use of Clustered Regular Interspaced Short Palindromic Repeats (CRISPR) is one of the many new technologies emerging in the field of genetic research. The technique is rapidly becoming a standard method to introduce mutations into cell lines and laboratory animals in order to understand the cause of serious diseases such as cancer and dementia and identify new therapies.</p><p> </p><p> </p><p> </p><p>The United Kingdom has a strong and clear regulatory framework that bans genetic modifications of the nuclear genome that can be inherited from one generation to another. The use of CRISPR is permissible in the UK in a research setting, as long as any research carried out has the appropriate approvals. In the case of human embryos, research but not treatment using these techniques would be permissible provided the UK national regulator, the Human Fertilisation and Embryology Authority, was satisfied that the research met the criteria set out in the Human Fertilisation and Embryology Act 1990, as amended.</p><p> </p> answering member constituency Mid Norfolk answering member printed George Freeman question first answered 12/06/2015 10:48:23 answering member 4020 label Biography information for George Freeman
tabling member	4129 label Biography information for Ian Paisley

348282

registered interest
date	03/06/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Muscular Dystrophy: Medical Treatments
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what discussions he has had with his counterparts in the devolved assemblies on (a) future decisions on the availability and (b) consistency of provision by area of drugs and treatment for Duchenne muscular dystrophy.
tabling member constituency	Strangford
tabling member printed	Jim Shannon
uin	938
answer	answer is ministerial correction date of answer 09/06/2015 answer text <p>No meetings have taken place between the Ministers of the Department and their counterparts in the devolved Assemblies to discuss drugs and treatments for Duchenne muscular dystrophy.</p><p> </p> answering member constituency Battersea answering member printed Jane Ellison question first answered 09/06/2015 14:40:22 answering member 3918 label Biography information for Jane Ellison
tabling member	4131 label Biography information for Jim Shannon